Skip to content
ClinCalc Pro
Menu
Effervescent calcium supplement

Calcium carbonate with calcium lactate gluconate

Brand names: Calcium-Sandoz, Calcichew

Used in: Osteoporosis

A combination of calcium carbonate and calcium lactate gluconate, usually supplied as an effervescent tablet that provides a soluble source of elemental calcium for prevention or treatment of calcium deficiency and as an adjunct in osteoporosis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Both salts dissociate to deliver elemental calcium, replenishing extracellular calcium and supporting bone mineralisation, neuromuscular function and the negative feedback that suppresses parathyroid hormone.

Prescribing in practice

  • Avoid in conditions associated with hypercalcaemia or hypercalciuria (such as certain malignancies, sarcoidosis or severe renal impairment) where further calcium loading can be harmful.
  • Separate dosing from oral tetracyclines, quinolones, levothyroxine, iron and bisphosphonates, as calcium chelates and reduces their absorption.
  • The effervescent preparation carries a notable sodium load, which is relevant in hypertension, heart failure or renal impairment.

Monitoring

Monitor serum calcium (and renal function) periodically, particularly with high-dose or long-term use or where there is a risk of hypercalcaemia.

Counselling the patient

  • Dissolve the effervescent tablet fully in water before drinking.
  • Take other medicines such as antibiotics or thyroid tablets a couple of hours apart from your calcium.
  • Report persistent nausea, constipation, excessive thirst or confusion, which can signal high calcium levels.

Evidence & guidelines

Calcium with vitamin D supplementation is recommended by NICE as an adjunct to osteoporosis treatment in those with inadequate dietary intake.

Reference: NICE NG121; ROS; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.